Ernest Seidman
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| The Impact of 6MP Metabolite Levels on Infliximab Pharmacokinetics and Anti-infliximab Antibodies in Crohn's Disease (NCT02453607) | Ernest Seidman | 2014-11-17 |
Track Ernest Seidman automatically
Every clearance here is in the API, with alerts when new ones post.